610 Matching Annotations
  1. Sep 2021
    1. Liu, W., Russell, R. M., Bibollet-Ruche, F., Skelly, A. N., Sherrill-Mix, S., Freeman, D. A., Stoltz, R., Lindemuth, E., Lee, F.-H., Sterrett, S., Bar, K. J., Erdmann, N., Gouma, S., Hensley, S. E., Ketas, T., Cupo, A., Cruz Portillo, V. M., Moore, J. P., Bieniasz, P. D., … Hahn, B. H. (2021). Predictors of Nonseroconversion after SARS-CoV-2 Infection. Emerging Infectious Diseases, 27(9), 2454–2458. https://doi.org/10.3201/eid2709.211042

  2. Aug 2021
    1. Liu, Y., Arase, N., Kishikawa, J., Hirose, M., Li, S., Tada, A., Matsuoka, S., Arakawa, A., Akamatsu, K., Ono, C., Jin, H., Kishida, K., Nakai, W., Kohyama, M., Nakagawa, A., Yamagishi, Y., Nakagami, H., Kumanogoh, A., Matsuura, Y., … Arase, H. (2021). The SARS-CoV-2 Delta variant is poised to acquire complete resistance to wild-type spike vaccines (p. 2021.08.22.457114). https://doi.org/10.1101/2021.08.22.457114

    1. John Burn-Murdoch. (2021, May 27). NEW: B.1617.2 is fuelling a third wave in the UK, with not only cases but also hospital admissions rising. Vaccines will make this wave different to those that have come before, but it remains a concern, and one that other countries will soon face. Thread on everything we know: Https://t.co/4825qOqgrl [Tweet]. @jburnmurdoch. https://twitter.com/jburnmurdoch/status/1397995388267810818

  3. Jul 2021
  4. Jun 2021
    1. Helen McArdle on Twitter: “The good news: An astonishing 98.2% of over-60s in Scotland are now fully vaccinated. That’s an amazing uptake. It doesn’t mean they are 100% protected of course (and especially not when case rates are high) but their risk of hospitalisation/death is cut by over 90% https://t.co/DzAxkpLvcR” / Twitter. (n.d.). Retrieved June 30, 2021, from https://twitter.com/HMcArdleHT/status/1409821893557768195

    1. Knock, E. S., Whittles, L. K., Lees, J. A., Perez-Guzman, P. N., Verity, R., FitzJohn, R. G., Gaythorpe, K. A. M., Imai, N., Hinsley, W., Okell, L. C., Rosello, A., Kantas, N., Walters, C. E., Bhatia, S., Watson, O. J., Whittaker, C., Cattarino, L., Boonyasiri, A., Djaafara, B. A., … Baguelin, M. (2021). Key epidemiological drivers and impact of interventions in the 2020 SARS-CoV-2 epidemic in England. Science Translational Medicine, eabg4262. https://doi.org/10.1126/scitranslmed.abg4262

    1. Thompson, M. G., Burgess, J. L., Naleway, A. L., Tyner, H. L., Yoon, S. K., Meece, J., Olsho, L. E. W., Caban-Martinez, A. J., Fowlkes, A., Lutrick, K., Kuntz, J. L., Dunnigan, K., Odean, M. J., Hegmann, K. T., Stefanski, E., Edwards, L. J., Schaefer-Solle, N., Grant, L., Ellingson, K., … Gaglani, M. (2021). Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers—Eight U.S. Locations, December 2020–March 2021. MMWR. Morbidity and Mortality Weekly Report, 70(13), 495–500. https://doi.org/10.15585/mmwr.mm7013e3

    1. Parry, H. M., Tut, G., Faustini, S., Stephens, C., Saunders, P., Bentley, C., Hilyard, K., Brown, K., Amirthalingam, G., Charlton, S., Leung, S., Chiplin, E., Coombes, N. S., Bewley, K. R., Penn, E. J., Rowe, C., Otter, A., Watts, R., D’Arcangelo, S., … Moss, P. (2021). BNT162b2 Vaccination in People Over 80 Years of Age Induces Strong Humoral Immune Responses with Cross Neutralisation of P.1 Brazilian Variant. SSRN Electronic Journal. https://doi.org/10.2139/ssrn.3816840

    1. Was there any domestic abuse in your family?Luisa: With my parents? My mother, yes. She doesn't like to talk about it. The older I get, the more she opens up, but it's not something that she likes to talk about. It was never in front of us, it was behind closed doors. I thank my father. He's a piece of shit, but I thank him for at least having the thought of not wanting to traumatize us. So yes, it was behind closed doors, but the more I get out of my mom, it was a lot of emotional abuse as well, a lot. I think there was some physical abuse. My mom's never touched upon it, but that's what happened.

      Time in the US, Migration from Mexico, Reasons, Domestic Violence

  5. May 2021
    1. Eric Topol. (2021, May 1). Downgrading the concern on B.1.617, the poorly named ‘double mutant’—98% effectiveness of mRNA vaccine in an Israeli outbreak @CT_Bergstrom https://t.co/tGbuwPUmAL —Lab studies: Minimal immune evasion, expected full protection from vaccine @GuptaR_lab https://t.co/AIp24G0ROK https://t.co/AK20UWlDBD [Tweet]. @EricTopol. https://twitter.com/EricTopol/status/1388539223230140422

    1. Sam Bowman. (2021, January 25). If the govt can’t keep a few thousand people fed in hotel quarantine, how exactly was it supposed to provide for fifteen million pensioners self-isolating in Great Barrington-style ‘focused protection’ while the virus was spreading across the rest of the population? [Tweet]. @s8mb. https://twitter.com/s8mb/status/1353666214883684352

    1. Howard, J., Huang, A., Li, Z., Tufekci, Z., Zdimal, V., Westhuizen, H.-M. van der, Delft, A. von, Price, A., Fridman, L., Tang, L.-H., Tang, V., Watson, G. L., Bax, C. E., Shaikh, R., Questier, F., Hernandez, D., Chu, L. F., Ramirez, C. M., & Rimoin, A. W. (2021). An evidence review of face masks against COVID-19. Proceedings of the National Academy of Sciences, 118(4). https://doi.org/10.1073/pnas.2014564118

    1. Jonathan Rothberg 🦋. (2021, March 2). Testing works. I test daily. Insist on HOME testing. @michaelmina_lab @JoeBiden Research suggests B.1.526 needs to be closely watched “for its ability to evade both monoclonal antibody and, to a certain extent, the vaccine-induced antibody,” said Fauci [Tweet]. @JMRothberg. https://twitter.com/JMRothberg/status/1366755339912306688

  6. Apr 2021
  7. Mar 2021
    1. “Follow your blisters” implies something that you come back to so many times that you eventually move past the blister stage, into toughened skin. Eventually, the activity “marks you” through use and practice, and you develop a special competence. When you practice an activity a bit more obsessively than other people, you build unique character – you earn some wear and some healing that makes you idiosyncratic, and a little unbalanced.It is something that you don’t need to put on your to-do list, something you care enough about to return to repeatedly, even though it causes discomfort. Over time, you develop a layer of protection that enables you to do that something more easily.
  8. Feb 2021
  9. Jan 2021
  10. Nov 2020
    1. Identify, classify, and apply protective measures to sensitive data. Data discovery and data classification solutions help to identify sensitive data and assign classification tags dictating the level of protection required. Data loss prevention solutions apply policy-based protections to sensitive data, such as encryption or blocking unauthorized actions, based on data classification and contextual factors including file type, user, intended recipient/destination, applications, and more. The combination of data discovery, classification, and DLP enable organizations to know what sensitive data they hold and where while ensuring that it's protected against unauthorized loss or exposure.

      [[BEST PRACTICES FOR DATA EGRESS MANAGEMENT AND PREVENTING SENSITIVE DATA LOSS]]

  11. Oct 2020
  12. Sep 2020
    1. Le Bert, N., Tan, A. T., Kunasegaran, K., Tham, C. Y. L., Hafezi, M., Chia, A., Chng, M. H. Y., Lin, M., Tan, N., Linster, M., Chia, W. N., Chen, M. I.-C., Wang, L.-F., Ooi, E. E., Kalimuddin, S., Tambyah, P. A., Low, J. G.-H., Tan, Y.-J., & Bertoletti, A. (2020). SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature, 584(7821), 457–462. https://doi.org/10.1038/s41586-020-2550-z

  13. Aug 2020
    1. Felipe, L. S., Vercruysse, T., Sharma, S., Ma, J., Lemmens, V., Looveren, D. van, Javarappa, M. P. A., Boudewijns, R., Malengier-Devlies, B., Kaptein, S. F., Liesenborghs, L., Keyzer, C. D., Bervoets, L., Rasulova, M., Seldeslachts, L., Jansen, S., Yakass, M. B., Quaye, O., Li, L.-H., … Dallmeier, K. (2020). A single-dose live-attenuated YF17D-vectored SARS-CoV2 vaccine candidate. BioRxiv, 2020.07.08.193045. https://doi.org/10.1101/2020.07.08.193045

    1. Corbett, K. S., Edwards, D. K., Leist, S. R., Abiona, O. M., Boyoglu-Barnum, S., Gillespie, R. A., Himansu, S., Schäfer, A., Ziwawo, C. T., DiPiazza, A. T., Dinnon, K. H., Elbashir, S. M., Shaw, C. A., Woods, A., Fritch, E. J., Martinez, D. R., Bock, K. W., Minai, M., Nagata, B. M., … Graham, B. S. (2020). SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. Nature, 1–8. https://doi.org/10.1038/s41586-020-2622-0

    1. Chen, Y., Yang, W.-H., Huang, L.-M., Wang, Y.-C., Yang, C.-S., Liu, Y.-L., Hou, M.-H., Tsai, C.-L., Chou, Y.-Z., Huang, B.-Y., Hung, C.-F., Hung, Y.-L., Chen, J.-S., Chiang, Y.-P., Cho, D.-Y., Jeng, L.-B., Tsai, C.-H., & Hung, M.-C. (2020). Inhibition of Severe Acute Respiratory Syndrome Coronavirus 2 main protease by tafenoquine in vitro. BioRxiv, 2020.08.14.250258. https://doi.org/10.1101/2020.08.14.250258

    1. Kreye, J., Reincke, S. M., Kornau, H.-C., Sánchez-Sendin, E., Corman, V. M., Liu, H., Yuan, M., Wu, N. C., Zhu, X., Lee, C.-C. D., Trimpert, J., Höltje, M., Dietert, K., Stöffler, L., Wardenburg, N. von, Hoof, S. van, Homeyer, M. A., Hoffmann, J., Abdelgawad, A., … Prüss, H. (2020). A SARS-CoV-2 neutralizing antibody protects from lung pathology in a COVID-19 hamster model. BioRxiv, 2020.08.15.252320. https://doi.org/10.1101/2020.08.15.252320

    1. Sun, W., McCroskery, S., Liu, W.-C., Leist, S. R., Liu, Y., Albrecht, R. A., Slamanig, S., Oliva, J., Amanat, F., Schäfer, A., Dinnon, K. H., Innis, B. L., García-Sastre, A., Krammer, F., Baric, R. S., & Palese, P. (2020). A Newcastle disease virus (NDV) expressing membrane-anchored spike as a cost-effective inactivated SARS-CoV-2 vaccine. BioRxiv, 2020.07.30.229120. https://doi.org/10.1101/2020.07.30.229120

  14. Jul 2020
  15. Jun 2020
    1. Chu, D. K., Akl, E. A., Duda, S., Solo, K., Yaacoub, S., Schünemann, H. J., Chu, D. K., Akl, E. A., El-harakeh, A., Bognanni, A., Lotfi, T., Loeb, M., Hajizadeh, A., Bak, A., Izcovich, A., Cuello-Garcia, C. A., Chen, C., Harris, D. J., Borowiack, E., … Schünemann, H. J. (2020). Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: A systematic review and meta-analysis. The Lancet, 0(0). https://doi.org/10.1016/S0140-6736(20)31142-9

  16. May 2020
    1. Betsch, C., Wieler, L., Bosnjak, M., Ramharter, M., Stollorz, V., Omer, S., Korn, L., Sprengholz, P., Felgendreff, L., Eitze, S., & Schmid, P. (2020). Germany COVID-19 Snapshot MOnitoring (COSMO Germany): Monitoring knowledge, risk perceptions, preventive behaviours, and public trust in the current coronavirus outbreak in Germany. https://doi.org/10.23668/PSYCHARCHIVES.2776

  17. Apr 2020
    1. Jefferson, T., Jones, M., Al Ansari, L. A., Bawazeer, G., Beller, E., Clark, J., Conly, J., Del Mar, C., Dooley, E., Ferroni, E., Glasziou, P., Hoffman, T., Thorning, S., & Van Driel, M. (2020). Physical interventions to interrupt or reduce the spread of respiratory viruses. Part 1 - Face masks, eye protection and person distancing: Systematic review and meta-analysis [Preprint]. Public and Global Health. https://doi.org/10.1101/2020.03.30.20047217

    1. School for many people is a place to get fed, a place to feel safe, a place to get encouraged. It’s a place to be around people who share your desire to learn. Now they are cut off from that, and some of that can’t be duplicated easily online.

      Yes, this is a problem. However... Schools weren't designed to be a safegaurd against poor parenting, but they're treated that way, as if they're a place to escape the idiots they live with.

      Schools shouldn't tolerate this. Instead, they should intervene. They should bring in a third party, someone/an organization specifically designed to help kids who come from broken homes, to help heal how they live when school's not in session. Any measure less than this signals, to me, a school system that's not paying attention to their student's emotional needs, which are, I believe, key to ensuring the child thrives throughout their school years.

  18. Aug 2019
  19. Feb 2019
  20. Jan 2019
    1. est également possible de réduire les émissions et la consommation d’énergies non renou-velables en Suisse en diminuant la production indigène et en augmentant les importations. Agir de la sorte est approprié si l’empreinte écologique d’un produit agricole importé est infé-rieure à celle du produit indigène correspondant et si la capacité de charge écologique sur le lieu de production n’est pas dépassée.

      attention à la justification pour l'ouverture des frontières en cas de négociation d'accords bilatéraux!

  21. Sep 2018
    1. However, courts might go further and address the concern that, even where government regulation of cognitive enhancement drugs is rooted in legitimate safety concerns, this should not—by itself—give the government authority to restrict individuals’ mental freedom or “cognitive liberty” far more than is necessary to address those safety concerns. Perhaps, for example, government has imposed a complete ban where something less restrictive will satisfy the safety concerns it is worried about. For example, the state might instead institute a “gatekeeper” system in which a doctor must assess and discuss risks for a particular individual before drugs are prescribed or require a mandatory course on side effects before use of cognitive enhancement drugs.

      I believe that this solution to the paragraph directly above it, directly contradicts itself. If the Government bans the use of a drug not because it can make someone happier/better, but because it can have potentially negative or harmful side affects, then this solution is impossible. If the government deems some as potentially harmful then in more cases than not it most probably is. In this way no government could rationally come to this solution rather than the one above it. It would be obscure for a Government to allow a person who is educated about the dangers of a product to choose to use it. In the Government's and the medical professional's eyes this person would not be in their 'right mind'.. How then, could they ever allow someone who they do not deem 'in their right mind' to use a potentially hazardous drug?

  22. Jul 2018
    1. Upon receipt of notification, the Authority shall determine whether such breach should be reported by the data fiduciaryto the data principal, taking into account the severity of the harm that may be caused to such data principal or whether some action is required on the part of the data principal to mitigate suchharm.

      This means that users aren't always informed about a breach of data. That's the prerogative of the Data Protection Authority, and not mandatory, in the interest of the user.

  23. Jan 2018